We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Tower Limited is an insurance-diversified business based in Australia. Tower shares (TWR) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Tower has a trailing 12-month revenue of around $332.9 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $0.5149 - $0.8064 |
|---|---|
| 50-day moving average | $0.6381 |
| 200-day moving average | $0.6936 |
| Target price | $0.49 |
| PE ratio | 30.75 |
| Dividend yield | $0.025 (4%) |
| Earnings per share (TTM) | $0.02 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.6
| 1 week (2021-10-19) | 0.6 |
|---|---|
| 1 month (2021-09-24) | -7.69% |
| 3 months (2021-07-26) | -8.40% |
| 6 months (2021-04-26) | -27.27% |
| 1 year (2020-10-26) | 12.15% |
|---|---|
| 2 years (2019-10-25) | -7.69% |
| 3 years (2018-10-26) | -12.27% |
| 5 years (2016-10-26) | -6.77% |
Valuing Tower stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tower 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tower 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 31x. In other words, Tower shares trade at around 31x recent earnings.
That's comparable to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14).
Tower 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $30.6 million (£0.0 million).
The EBITDA is a measure of a Tower 's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $332.9 million |
|---|---|
| Operating margin TTM | 9% |
| Gross profit TTM | $37.5 million |
| Return on assets TTM | 2.51% |
| Return on equity TTM | 2.68% |
| Profit margin | 2.7% |
| Book value | 0.842 |
| Market capitalisation | $259.3 million |
TTM: trailing 12 months
We're not expecting Tower to pay a dividend over the next 12 months.
Tower 's shares were split on a 10:13 basis on 2 April 2013. So if you had owned 13 shares the day before before the split, the next day you'd have owned 10 shares. This wouldn't directly have changed the overall worth of your Tower shares – just the quantity. However, indirectly, the new 30% higher share price could have impacted the market appetite for Tower shares which in turn could have impacted Tower 's share price.
Over the last 12 months, Tower 's shares have ranged in value from as little as $0.5149 up to $0.8064. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Tower 's is 0.4339. This would suggest that Tower 's shares are less volatile than average (for this exchange).
Tower Limited provides general insurance products in New Zealand and the Pacific Islands. Its insurance products include car, contents, renters', house, landlord, business, travel, boat, motorbike, lifestyle block and farm, motorhome, and caravan or trailer insurance. The company was founded in 1869 and is based in Auckland, New Zealand.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Shares in the wealth management giant have been largely stable in the last 6 months.
Everything we know about the Judo Capital Holdings IPO, plus information on how to buy in.
Everything we know about the Alloggio Group IPO, plus information on how to buy in.
Everything we know about the Larvotto Resources IPO, plus information on how to buy in.
Everything we know about the Vulcan Steel IPO, plus information on how to buy in.
Everything we know about the Artrya IPO, plus information on how to buy in.
Everything we know about the 8 Au IPO, plus information on how to buy in.
Everything we know about the Radiopharm Theranostics IPO, plus information on how to buy in.
The online retailer’s shares have lost more than half their value in the last 12 months.
